Samumed Competitors and Similar CompaniesClear all
Roivant Sciences's competitors and similar companies include AdAlta.
 AdAlta AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies. | ||
Founding Date | Founding Date 2014 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Bundoora, AU HQ Melbourne, AU |
Employees | Employees 908 | Employees 9 |
Valuation ($) | Valuation ($) 8.8 b | Valuation ($) 7.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($397.9m) (FY, 2025) | Net income ($4.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 1.9b | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
AdAlta
HQ
Bundoora, AU
Employees
9
AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies.
View company